Claudio Brunstein
Experienced in Relapsing Multiple Sclerosis (RMS)

Dr. Claudio Brunstein

Hematology Oncology | Hematology | Oncology
Cleveland Clinic
Cleveland Clinic Main Campus
10201 Carnegie Avenue, 
Cleveland, OH 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
30 Years of Experience
Experienced in Relapsing Multiple Sclerosis (RMS)
Cleveland Clinic
Cleveland Clinic Main Campus
10201 Carnegie Avenue, 
Cleveland, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Claudio Brunstein is a Hematologist Oncology specialist and a Hematologist in Cleveland, Ohio. Dr. Brunstein has been practicing medicine for over 30 years and is rated as an Experienced provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 168 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Not Applicable
Residency
Hospital de Clinicas de Porto Alegre
Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in MN
Board Certifications
American Board Of Internal Medicine, 2017
Fellowships
University of Minnesota
Hospital Affiliations
Cleveland Clinic
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Provider Partners Health Plan
  • MEDICARE SNP
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
SummaCare
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 26 Less Insurance Carriers -

Locations

Cleveland Clinic Main Campus
10201 Carnegie Avenue, Cleveland, OH 44106
Call: 866-223-8100

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
Enrollment Status: Recruiting
Publish Date: February 03, 2025
Intervention Type: Biological
Study Phase: Not Applicable
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
Enrollment Status: Completed
Publish Date: August 19, 2025
Intervention Type: Other
Study Phase: Not Applicable
Transplantation of Umbilical Cord Blood From Unrelated Donors in Patients With Hematological Diseases Using a Non-Myeloablative Preparative Regimen
Transplantation of Umbilical Cord Blood From Unrelated Donors in Patients With Hematological Diseases Using a Non-Myeloablative Preparative Regimen
Enrollment Status: Completed
Publish Date: July 04, 2025
Intervention Type: Radiation, Biological, Drug
Study Drugs: Fludarabine, Cyclophosphamide, Mycophenolate Mofetil, Sirolimus, Anti-Thymocyte Globulin
Study Phase: Phase 2
An Open Label Expanded Access Study of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies
An Open Label Expanded Access Study of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies
Enrollment Status: Completed
Publish Date: July 02, 2025
Intervention Type: Biological
Study Phase: Phase 3
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haploidentical Related Hematopoietic Cells (Haplo-HCT) For Patients With Hematologic Malignancies
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haploidentical Related Hematopoietic Cells (Haplo-HCT) For Patients With Hematologic Malignancies
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Biological, Drug
Study Drugs: Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil
Study Phase: Phase 2
A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, UCB-derived, Stem and Progenitor Cells, vs. Unmanipulated UCB for Patients With Hematological Malignancies
A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, UCB-derived, Stem and Progenitor Cells, vs. Unmanipulated UCB for Patients With Hematological Malignancies
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Drug, Other
Study Drug: Omidubicel
Study Phase: Phase 3
MT2014-10C: Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathies and Other Red Cell Transfusion Dependent Disorders
MT2014-10C: Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathies and Other Red Cell Transfusion Dependent Disorders
Enrollment Status: Terminated
Publish Date: March 03, 2025
Intervention Type: Drug
Study Phase: Not Applicable
QUILT-3.033: Haploidentical Donor Natural Killer (NK) Cell Infusion With Subcutaneous ALT-803 in Adults With Refractory or Relapsed Acute Myelogenous Leukemia
QUILT-3.033: Haploidentical Donor Natural Killer (NK) Cell Infusion With Subcutaneous ALT-803 in Adults With Refractory or Relapsed Acute Myelogenous Leukemia
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Biological
Study Phase: Phase 2
View 7 Less Clinical Trials

168 Total Publications

Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 18, 2025
View All 168 Publications
Similar Doctors
Experienced in Relapsing Multiple Sclerosis (RMS)
Dr. Nashat Y. Gabrail
Hematology | Oncology
Experienced in Relapsing Multiple Sclerosis (RMS)
Dr. Nashat Y. Gabrail
Hematology | Oncology
4875 Higbee Ave Nw, 
Canton, OH 
 (45.9 miles away)
330-492-3345
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Nashat Gabrail is a Hematologist and an Oncologist in Canton, Ohio. Dr. Gabrail is rated as an Advanced provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Blood Clots, Multiple Myeloma, Lung Cancer, and Relapsed Refractory Multiple Myeloma (RRMM). Dr. Gabrail is currently accepting new patients.

Brian R. Murphy
Experienced in Relapsing Multiple Sclerosis (RMS)
Dr. Brian R. Murphy
Hematology | Oncology
Experienced in Relapsing Multiple Sclerosis (RMS)
Dr. Brian R. Murphy
Hematology | Oncology

Cancer Center, Sandusky

417 Quarry Lakes Dr, 
Sandusky, OH 
 (59.2 miles away)
Languages Spoken:
English
See accepted insurances

Brian Murphy is a Hematologist and an Oncologist in Sandusky, Ohio. Dr. Murphy is rated as a Distinguished provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Breast Cancer, Small Cell Lung Cancer (SCLC), Lung Cancer, and Pleuropulmonary Blastoma.

Kasra Karamlou
Experienced in Relapsing Multiple Sclerosis (RMS)
Dr. Kasra Karamlou
Hematology
Experienced in Relapsing Multiple Sclerosis (RMS)
Dr. Kasra Karamlou
Hematology

Cleveland Clinic

9500 Euclid Ave, 
Cleveland, OH 
 (0.3 miles away)
216-442-1270
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kasra Karamlou is a Hematologist in Cleveland, Ohio. Dr. Karamlou is rated as an Advanced provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Chronic Lymphocytic Leukemia (CLL), Unicentric Castleman Disease (UCD), and Multicentric Castleman Disease (MCD).

VIEW MORE RELAPSING MULTIPLE SCLEROSIS (RMS) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brunstein's expertise for a condition
ConditionClose
    • Distinguished
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Brunstein is
      Distinguished
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Brunstein is
      Distinguished
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Bone Marrow Transplant
      Dr. Brunstein is
      Distinguished
      . Learn about Bone Marrow Transplant.
      See more Bone Marrow Transplant experts
    • Graft Versus Host Disease (GvHD)
      Dr. Brunstein is
      Distinguished
      . Learn about Graft Versus Host Disease (GvHD).
      See more Graft Versus Host Disease (GvHD) experts
    • Multiple Myeloma
      Dr. Brunstein is
      Distinguished
      . Learn about Multiple Myeloma.
      See more Multiple Myeloma experts
    • Myelodysplastic Syndrome (MDS)
      Dr. Brunstein is
      Distinguished
      . Learn about Myelodysplastic Syndrome (MDS).
      See more Myelodysplastic Syndrome (MDS) experts
    • Advanced
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Brunstein is
      Advanced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Brunstein is
      Advanced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Burkitt Lymphoma
      Dr. Brunstein is
      Advanced
      . Learn about Burkitt Lymphoma.
      See more Burkitt Lymphoma experts
    • Childhood Acute Myeloid Leukemia
      Dr. Brunstein is
      Advanced
      . Learn about Childhood Acute Myeloid Leukemia.
      See more Childhood Acute Myeloid Leukemia experts
    • Chronic Myelogenous Leukemia (CML)
      Dr. Brunstein is
      Advanced
      . Learn about Chronic Myelogenous Leukemia (CML).
      See more Chronic Myelogenous Leukemia (CML) experts
    • Chronic Myelomonocytic Leukemia (CMML)
      Dr. Brunstein is
      Advanced
      . Learn about Chronic Myelomonocytic Leukemia (CMML).
      See more Chronic Myelomonocytic Leukemia (CMML) experts
    View All 13 Advanced Conditions
    • Experienced
    • Acute Promyelocytic Leukemia
      Dr. Brunstein is
      Experienced
      . Learn about Acute Promyelocytic Leukemia.
      See more Acute Promyelocytic Leukemia experts
    • Adult T-Cell Leukemia
      Dr. Brunstein is
      Experienced
      . Learn about Adult T-Cell Leukemia.
      See more Adult T-Cell Leukemia experts
    • Agranulocytosis
      Dr. Brunstein is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Anal Cancer
      Dr. Brunstein is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Anaplastic Large Cell Lymphoma
      Dr. Brunstein is
      Experienced
      . Learn about Anaplastic Large Cell Lymphoma.
      See more Anaplastic Large Cell Lymphoma experts
    • Anemia
      Dr. Brunstein is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    View All 55 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Close
        0 / 1000

        Please provide us with the below insurance information:

                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.